101 related articles for article (PubMed ID: 14607952)
21. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.
Kawabata Y; Udono H; Honma K; Ueda M; Mukae H; Kadota J; Kohno S; Yui K
Infect Immun; 2002 Nov; 70(11):6075-82. PubMed ID: 12379684
[TBL] [Abstract][Full Text] [Related]
22. Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers.
Sedegah M; Belmonte M; Epstein JE; Siegrist CA; Weiss WR; Jones TR; Lu M; Carucci DJ; Hoffman SL
J Immunol; 2003 Sep; 171(6):3148-53. PubMed ID: 12960342
[TBL] [Abstract][Full Text] [Related]
23. Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection.
Wipasa J; Xu H; Stowers A; Good MF
J Immunol; 2001 Oct; 167(7):3903-9. PubMed ID: 11564808
[TBL] [Abstract][Full Text] [Related]
24. Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.
Eslava I; Payares G; Pernia BM; Holder AA; Spencer LM
Malar J; 2010 Feb; 9():46. PubMed ID: 20146804
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
26. Production, characterisation and immunogenicity of a plant-made Plasmodium antigen--the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1.
Ma C; Wang L; Webster DE; Campbell AE; Coppel RL
Appl Microbiol Biotechnol; 2012 Apr; 94(1):151-61. PubMed ID: 22170105
[TBL] [Abstract][Full Text] [Related]
27. Disulfide bonds in merozoite surface protein 1 of the malaria parasite impede efficient antigen processing and affect the in vivo antibody response.
Hensmann M; Li C; Moss C; Lindo V; Greer F; Watts C; Ogun SA; Holder AA; Langhorne J
Eur J Immunol; 2004 Mar; 34(3):639-648. PubMed ID: 14991593
[TBL] [Abstract][Full Text] [Related]
28. Isolation and Characterization of Vaccine Candidate Genes Including
Kim SH; Bae YA; Seoh JY; Yang HJ
Korean J Parasitol; 2017 Jun; 55(3):255-265. PubMed ID: 28719950
[TBL] [Abstract][Full Text] [Related]
29. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
Burns JM; Majarian WR; Young JF; Daly TM; Long CA
J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
[TBL] [Abstract][Full Text] [Related]
30. Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice.
Hirunpetcharat C; Stanisic D; Liu XQ; Vadolas J; Strugnell RA; Lee R; Miller LH; Kaslow DC; Good MF
Parasite Immunol; 1998 Sep; 20(9):413-20. PubMed ID: 9767608
[TBL] [Abstract][Full Text] [Related]
31. Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice.
Miyata T; Harakuni T; Taira T; Matsuzaki G; Arakawa T
Vaccine; 2012 Jan; 30(5):948-58. PubMed ID: 22119928
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory antibodies specific for the 19-kilodalton fragment of merozoite surface protein 1 do not correlate with delayed appearance of infection with Plasmodium falciparum in semi-immune individuals in Vietnam.
Murhandarwati EE; Wang L; Black CG; Nhan DH; Richie TL; Coppel RL
Infect Immun; 2009 Oct; 77(10):4510-7. PubMed ID: 19620342
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.
Matsumoto S; Yukitake H; Kanbara H; Yamada H; Kitamura A; Yamada T
Vaccine; 2000 Nov; 19(7-8):779-87. PubMed ID: 11115699
[TBL] [Abstract][Full Text] [Related]
34. Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.
Lozano JM; Lesmes LP; Gallego GM; Patarroyo ME
Mol Immunol; 2011 Jan; 48(4):657-69. PubMed ID: 21131051
[TBL] [Abstract][Full Text] [Related]
35. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
[TBL] [Abstract][Full Text] [Related]
36. Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1.
Wipasa J; Xu H; Makobongo M; Gatton M; Stowers A; Good MF
Infect Immun; 2002 Nov; 70(11):6013-20. PubMed ID: 12379677
[TBL] [Abstract][Full Text] [Related]
37. Immunological responses of neonates and infants to DNA vaccines.
Sedegah M; Hoffman SL
Methods Mol Med; 2006; 127():239-51. PubMed ID: 16988458
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.
Vukovic P; Hogarth PM; Barnes N; Kaslow DC; Good MF
Infect Immun; 2000 May; 68(5):3019-22. PubMed ID: 10769007
[TBL] [Abstract][Full Text] [Related]
39. Immunity to erythrocytic stages of malarial parasites.
Long CA; Daly TM; Kima P; Srivastava I
Am J Trop Med Hyg; 1994; 50(4 Suppl):27-32. PubMed ID: 7909653
[TBL] [Abstract][Full Text] [Related]
40. The rodent malaria lactate dehydrogenase assay provides a high throughput solution for in vivo vaccine studies.
Otsuki H; Yokouchi Y; Iyoku N; Tachibana M; Tsuboi T; Torii M
Parasitol Int; 2015 Aug; 64(4):60-3. PubMed ID: 25701649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
